Norberto Prestes, director of the Brazilian Pharmochemicals Manufacturers Association (ABIQUIFI), provides insights into the main dynamics that have been shaping Brazil’s pharmaceutical and API sectors over the past few years, while highlighting his main priorities to further strengthen the country’s pharma industry both inside and outside Brazil.
What would you highlight as the main dynamics that have been shaping the domestic industry over the past few years?
"As ABIQUIFI, we are now working closely with the government and regulatory authorities to change the country’s paradigm in this regard and – for example - provide finished products using locally manufactured raw materials with a priority access to the Brazilian market."
